Senior Manager, Market Research - Liver
Gilead Sciences
Summary
As the Senior Manager, Market Research, you will report to the Liver Market Research Lead and will be responsible for leading primary market research initiatives across viral hepatitis (HBV, HCV, and HDV) in the US. You will lead market research projects and translate insights into actionable recommendations that inform commercial tactics and strategy. The position will partner closely with cross-functional stakeholders and present findings to Brand and Integrated Insights partners to help inform key strategic and tactical decisions.
Job description
Key Responsibilities
Market Research & Insights
- Partner with Marketing and Integrated Insights stakeholders to identify key business questions and research needs
- Lead end-to-end qualitative and quantitative market research projects among HCPs and patients, including objective setting, study design, vendor oversight, data collection, analysis, interpretation, and storytelling
- Develop clear and compelling presentations of market research insights for key stakeholders, including Brand leadership and senior management
- Keep abreast of key market events and assess their potential impact on Gilead's Liver business
Leadership, Influence & Collaboration
- Collaborate with cross-functional partners, including Commercial and Sales Analytics, Forecasting, Global, Managed Markets, and Brand, to understand sales and market trends and identify opportunities for additional research or insight generation
- Contribute insights and recommendations that help clarify trends, support decision-making, and inform business actions
- Communicate effectively, both verbally and in writing, with peers and cross-functional stakeholders
- Build strong working relationships across functions and contribute to a collaborative team environment
Project Management
- Manage multiple projects against tight timelines in an environment of changing priorities
- Oversee market research vendors, including project scope, timelines, budgets, deliverables, and the quality of outputs
- Apply strong planning, prioritization, and execution skills to keep work moving efficiently
Liver Commercial Analytics Cross-Training
The role may include opportunities for cross-training in Liver Commercial Analytics to broaden understanding of commercial performance and complement market research insights.
Requirements
- Bachelor's Degree and Eight Years' Experience OR Masters' Degree and Six Years' Experience OR PhD and Two Years' Experience
- Experience in biopharma, healthcare, market research, integrated insights, analytics, or related strategic functions
- Experience designing and conducting qualitative and quantitative primary market research
- Experience managing external vendors and leading projects from design through delivery
- Ability to synthesize findings into clear, actionable insights for business stakeholders
- In-depth experience in primary market research and the ability to ramp up quickly in a competitive market
Benefits
- Medical, Dental & Vision
- Life Insurance
- Paid Time Off
- Discretionary Annual Bonus
- Stock-Based Long-Term Incentives
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.